NanoVibronix Completes Application Process for Reimbursement Code for UroShield
August 05 2021 - 9:22AM
Dow Jones News
By Chris Wack
NanoVibronix Inc. said it has completed the application process
with the Centers for Medicare and Medicaid to receive a
reimbursement code for its UroShield and PainShield Plus
devices.
The medical-device company said applying for a CMS reimbursement
code for UroShield and PainShield Plus is a next step towards
seeking to materially increase the number of providers who may
prescribe its devices as therapies for patients, particularly
Medicare beneficiaries.
NanoVibronix's UroShield is an ultrasound-based product that is
designed to prevent bacterial colonization and biofilm on
indwelling urinary catheters and increase antibiotic efficacy.
UroShield is also intended to decrease pain and discomfort
associated with urinary catheter use.
PainShield Plus uses ultrasound therapy for the treatment of
pain and various soft tissue injuries either directly over joints
or orthopedic hardware and without the need for messy ultrasound
gels.
NanoVibronix shares were up 10%, to $2.24, in premarket
trading.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
August 05, 2021 09:22 ET (13:22 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.